Company performance
Add to research
Current Price
as of Feb 05, 2025$86.42
P/E Ratio
27.32
Market Cap
$383.21B
Description
Add to research
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Metrics
Add to research
Overview
- HQBagsværd, CR
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerNOVO.B
- Price$86.418909+5.29%
Trading Information
- Market cap$383.21B
- Float70.97%
- Average Daily Volume (1m)4,228,178
- Average Daily Volume (3m)4,124,139
- EPS$22.67
Company
- Revenue$290.40B
- Rev growth (1yr)25.03%
- Net income$100.99B
- Gross margin83.85%
- EBITDA margin50.95%
- EBITDA$147.95B
- EV$2.86T
- EV/Revenue9.86
- P/E27.32
- P/S9.52
- P/B22.69
Documents
Add to research
Factset Street Account
Wikipedia